Recent News


BG Medicine Announces Positive Pivotal Validation Study Results for CardioSCORE, a New Diagnostic Blood Test to Identify Individuals at High Risk for Near-term Major Cardiovascular Events February 13, 2012
BG Medicine, Inc. Appoints Brian S. Posner to its Board of Directors February 13, 2012
JOULE ELECTS ANATOLY CHUBAIS TO BOARD OF DIRECTORS February 2, 2012
T2 Biosystems Announces Issuance of Key Patent Providing Broad Intellectual Property Protection for Direct Detection Diagnostic Methods February 2, 2012
Avedro Announces Canadian Approval for Lasik Xtra™ January 31, 2012
Affinnova Launches Concept Studio for Collaborative Innovation January 26, 2012
BARDA biothreat contract could bring $40M to Tetraphase January 25, 2012
Joule Prepares for Global Deployment with Appointment of Proven Industry Experts to Lead Commercial Operations January 23, 2012
Selventa Granted Patent for Discovery of Biomarker Profiles January 23, 2012
Oasys Water Appoints Bob Muscat as New Chief Executive Officer to Drive Commercialization January 23, 2012
Affinnova Helps Sbarro Serve up an Optimized Pricing Strategy January 18, 2012
Tetraphase Appoints L. Patrick Gage, Ph.D., as Chairman of the Board January 18, 2012
JOULE SECURES $70M IN PRIVATE EQUITY INVESTMENTS FOR GROWTH January 17, 2012
Breathable Foods® Announces the Retail Launch of AeroShot Pure Energy™ January 17, 2012
Novomer and Penford Enter into Joint Development Agreement January 17, 2012
FLAGSHIP VENTURES CLOSES $270 MILLION EARLY-STAGE VENTURE CAPITAL FUND January 11, 2012
‘Beating heart’ transplants could boost success rate January 11, 2012
Receptos Achieves Milestone Under License of G-Protein Coupled Receptor Crystal Structure Determination Technology January 10, 2012
BG Medicine, Inc. Appoints Eric Bouvier as Chief Executive Officer January 9, 2012
Blend Therapeutics Founded by Leading Researchers in Chemistry and Nanomedicine to Develop a New Class of Integrative Combination Medicines January 6, 2012
CIA's In-Q-Tel makes strategic investment in Quanterix January 5, 2012
Ensemble Therapeutics Extends Macrocycle Drug Discovery Alliance with Bristol-Myers Squibb January 5, 2012
Ensemble Therapeutics Advances Macrocycle IL-17 Antagonist Program: Reports First Known Small Molecule Inhibitors of Important Autoimmune Target January 5, 2012
Avedro Announces CE Approval for Lasik Xtra ™ January 4, 2012
Drawing blood with a tap, not a sting - Cambridge firm’s device uses tiny needles, vacuum for painless diagnostic tests January 2, 2012
BG Medicine, Inc. Files 510(k) for AMIPredict December 28, 2011
Acceleron Secures $30M Private Financing December 23, 2011
Quanterix Develops Microfluidic Consumable That Will Enable Next Generation Molecular Diagnostic Systems based on Single Molecule Array Technology December 22, 2011
Seventh Sense Biosystems Receives $3.28 Million Grand Challenges Point-of-Care Diagnostics Grant to Expand Touch Activated Phlebotomy(TM) Technology Platform December 16, 2011
Mascoma Awarded $80 Million from the DOE for Construction of Commercial-Scale Hardwood Cellulosic Ethanol Facility in Kinross, Michigan December 14, 2011
Affinnova Delivers a Shot of Innovation for Breathable Foods December 12, 2011
Receptos and Ono Establish Collaboration with Focus on Bioactive Lipid Discovery Research December 12, 2011
Mascoma and Valero Establish Joint Venture for Commercial-Scale Hardwood Cellulosic Ethanol Facility in Kinross, Michigan December 9, 2011
Avedro Announces Its Second FDA Orphan Drug Designation for Corneal Cross-linking December 7, 2011
Quanterix Receives Funding From the Department of Homeland Security to Develop Test for Botulinum Toxin December 1, 2011
BG Medicine, Inc. Announces Peer-Reviewed Publication on Galectin-3 and Development of Heart Failure After Acute Coronary Syndrome (ACS) November 30, 2011
Affinnova to Continue Expansion in 2012 November 30, 2011
TARIS™ Initiates Phase 2 Clinical Study with LiRIS® in Interstitial Cystitis Patients November 30, 2011
Alvine's ALV003 Named a Top 10 Inflammatory/Autoimmune Project to Watch by Windhover for a Rare Second Year November 29, 2011
Abbie Celniker - FierceBiotech's 2011 Women in Biotech November 29, 2011
Testing vaccine to block nicotine November 27, 2011
Selecta Biosciences Initiates Phase 1 Clinical Study of SEL-068, a First-in-Class Synthetic Nicotine Vaccine for Smoking Cessation and Relapse Prevention November 21, 2011
CEO Corner: Hiring Veterans November 20, 2011
One-on-One with Dan Adelman of Alvine Pharmaceuticals November 18, 2011
Agios Secures $78 Million in Oversubscribed Series C Financing November 17, 2011
Concert Pharmaceuticals Announces NIH Research Collaboration for Rare and Neglected Diseases November 15, 2011
Celexion licensee BioAmber registers for IPO November 14, 2011
LS9 Significantly Expands Production November 7, 2011
BG Medicine, Inc. Announces Availability of Galectin-3 Testing Through Cleveland HeartLab, Inc. October 27, 2011
RUSNANO invests in Selecta Biosciences and BIND Biosciences to develop and commercialize vaccines and cancer drugs through expanded operations in Russia October 27, 2011
Alvine Pharmaceuticals Presents Additional Efficacy Data From Phase 2a Trial of ALV003 in Celiac Disease Patients October 24, 2011
T2 Biosystems Announces the Presentation of Data on Direct Detection with T2Candida October 21, 2011
Computer Backup Company Uses Affinnova's Technology to Advance its Advertising Strategy October 19, 2011
Concert Pharmaceuticals Announces Data Presentations at Neuroscience 2011 October 19, 2011
Concert Pharmaceuticals Announces CTP-499 Data Presentations at the American Society of Nephrology (ASN) Kidney Week Meeting October 19, 2011
Novomer Wins ICIS Award for Innovation with Best Environmental Benefit October 19, 2011
Joule Wins Prestigious Wall Street Journal Technology Innovation Award October 18, 2011
Innovation Awards: Polymers put CO2 to use October 17, 2011
Theracrine Announces Publication Identifying Potential Novel Cancer Spread Target October 17, 2011
Joule Unlimited Forges a Faster Path to Biofuels October 16, 2011
Avedro Appoints A. John Kanellopoulos, MD to Its Medical Advisory Board October 13, 2011
Black Duck Software Secures $12 Million in New Funding Round Led By Split Rock Partners October 13, 2011
Quanterix PSA Test Found to be a Reliable Predictor of Prostate Cancer Recurrence Following Surgery October 13, 2011
Alvine Pharmaceuticals Announces Positive Results From Phase 2a Trial of ALV003 in Celiac Disease Patients October 11, 2011
Celgene and Agios Extend Cancer Metabolism Collaboration October 5, 2011
Avedro Appoints C. Evan Ballantyne as Chief Financial Officer September 28, 2011
Theracrine Appoints Steven Kelly as President and CEO September 27, 2011
Eleven Biotherapeutics Appoints Abbie Celniker, Ph.D., Chief Executive Officer; September 22, 2011
Marc Tessier-Lavigne, Ph.D., President of The Rockefeller University, Joins Agios Board of Directors September 20, 2011
Former Millipore CEO takes helm at VC-backed Quanterix September 19, 2011
Mascoma Corporation Files Registration Statement for Proposed Initial Public Offering September 19, 2011
Ze-gen Selected by AlwaysOn as a GoingGreen Global 200 Winner September 14, 2011
Flagship Ventures Managing Partner Dr. Noubar Afeyan to Accept 2012 Technology Pioneer Award on Behalf of Joule Unlimited at WEF's "Summer Davos" Meeting September 13, 2011
Mass High Tech reports "Avedro scores FDA advancement for eye disease treatment" September 12, 2011
FierceBiotech Names Selecta Biosciences a 2011 Fierce 15 Biotech September 6, 2011
BG Medicine, Inc. to Present at Baird's 2011 Health Care Conference September 1, 2011
Joule Named 2012 Technology Pioneer by World Economic Forum September 1, 2011
Preclinical Studies Support Galectin-3 as a New Drug Target in Heart Failure - Results Presented at European Society of Cardiology (ESC) Congress 2011 August 31, 2011
Helicos BioSciences Expands Its License with Arizona Technology Enterprises Covering Next Generation Sequencing; New Patents Continue to Issue August 30, 2011
Results of First Epidemiological Study of Galectin-3: Higher Levels Are Associated With an Increased Risk of Mortality August 30, 2011
Study Shows Galectin-3 Predicts Response to Statin Therapy in Chronic Heart Failure - Results Presented at European Society of Cardiology (ESC) Congress 2011 August 29, 2011
Los Angeles Times features TransMedics' Organ Care System August 29, 2011
Permeon Biologics Boldly Go Where No MAb's Gone Before August 19, 2011
BG Medicine Announces Fiscal 2011 Second Quarter Results August 11, 2011
T2 Biosystems Completes $23 Million Series D Financing August 10, 2011
Stéphane Bancel, Former bioMérieux CEO, Talks Future of Startups, Diagnostics, Pharma August 4, 2011
Acceleron Pharma Announces Global Collaboration with Celgene Corporation on ACE-536 Program August 3, 2011
Permeon Biologics Announces Discovery of Human Intraphilin™ Proteins as a Novel Approach to Develop Intracellular Biologic Drugs July 28, 2011
BG Medicine, Inc. Appoints Stephane Bancel as Executive Chairman of the Board July 27, 2011
Joule Awarded Patents for High-Volume Ethanol Production from Sunlight and CO2 July 26, 2011
Quanterix and Sony DADC to Develop and Manufacture Smart Consumables for Life Science and In Vitro Diagnostic Applications July 20, 2011
LS9 AND HCL CLEANTECH AWARDED A $9 MILLION GRANT FROM THE DEPARTMENT OF ENERGY July 18, 2011
The Boston Globe features Affinnova, "The perfect supermarket cereal aisle?" July 15, 2011
Agios and Whitehead Institute Collaborate on Nature Publication Revealing Altered Metabolic Pathway in Breast Cancer July 14, 2011
Cambridge startup has tech to grow nutrients without farmland July 13, 2011
LS9 Extends Research In Synthetic Hydrocarbon Products with Chevron July 11, 2011
LS9 Planning Brazil’s Biggest Plant to Make Biofuels, Chemicals July 8, 2011
LS9 Announces Collaboration with MAN Latin America To Test LS9's UltraClean Diesel in Brazilian Fleet July 7, 2011
RISING STAR: Flagship's Berry Harkens Back To Venture Capital's Roots July 1, 2011
Concert Announces Milestone Achievement in GlaxoSmithKline Collaboration June 20, 2011
Concert Pharmaceuticals Announces Advancement of Novel Drug Candidates in Kidney Disease and Spasticity June 20, 2011
The Juvenile Diabetes Research Foundation and Selecta Biosciences Enter Research Collaboration for Vaccines for Type 1 Diabetes June 9, 2011
AVEO Pharmaceuticals Enters into Worldwide License Agreement with Centocor Ortho Biotech to Develop and Commercialize RON-Targeted Antibodies May 31, 2011
TARIS Biomedical Keeps Delivering Drugs Direct-to-the-Bladder May 26, 2011
Scientific founder of AVEO, Dr. DePinho, named President of the MD Anderson Cancer Center May 16, 2011
Ze-gen Names Robertson COO and Prendergast CFO May 16, 2011
Black Duck Software Named Winner of the 2011 New England Innovation Awards Program May 12, 2011
Seventh Sense Biosystems Secures $4.5M from $10M Series A Offering May 11, 2011
BG Medicine Announces Achievement of Two Significant Milestones for AMIPredict™ May 11, 2011
Joule Secures First of Multiple Sites to Host Solar Fuel Production May 5, 2011
Concert Pharmaceuticals Presents Preclinical Data on Novel Deuterium-Containing Drug Compound at Antiepileptic Drug Trials XI Conference May 2, 2011
On the hunt for green-tech game changers April 22, 2011
Brain Storm: David Berry Profile in Boston Magazine April 20, 2011
U.S. Clean Tech Industry At A Crossroads April 20, 2011
TARIS CLOSES $18.3 MILLION SERIES B FINANCING April 13, 2011
Ensemble Therapeutics Achieves Milestone in Bristol-Myers Squibb Collaboration April 12, 2011
AVEO Pharmaceuticals Appoints Henri A. Termeer to its Board of Directors April 12, 2011
Seventh Sense Biosystems Receives Gold Medal Edison Award April 8, 2011
Ethanol Industry Hoping for Surge March 31, 2011
Concert Pharmaceuticals Advances Novel Chronic Kidney Disease Treatment, CTP-499, in Phase 1 Clinical Study March 29, 2011
Selventa Announces a Joint Technology Collaboration with Pfizer Inc., to Include Developing Knowledge-sharing Portal of Biological Networks for the Scientific Community March 28, 2011
Advanced Electron Beams Introduces 2nd ITB Electron Beam Emitter for Aseptic Bottle Filling March 24, 2011
BD Completes Acquisition of Accuri Cytometers, Inc. March 18, 2011
Flagship VentureLabs Spawns New Cos. Essentient, Permeon Biologics March 16, 2011
BioAmber and CELEXION Announce Exclusive Licensing Partnership March 15, 2011
Flagship's Noubar Afeyan quoted in New York Times story, "Alt-Fuel Hopefuls Make Plays for Oil Companies' Cash" March 11, 2011
Quanterix Announces Publication of Novel Method Expanding Single Molecule Detection Capability February 23, 2011
Quanterix Announces New Technology Evaluation Agreement February 22, 2011
MIT’s Technology Review Unveils 2011 TR50 List of the World’s Most Innovative Companies February 22, 2011